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Fibronectin (Fn) forms a fibrillar network that controls cell behavior in both physiological and diseased
conditions including cancer. Indeed, breast cancer-associated stromal cells not only increase the quantity
of deposited Fn but also modify its conformation. However, (i) the interplay between mechanical and
conformational properties of early tumor-associated Fn networks and (ii) its effect on tumor vasculari-
zation remain unclear. Here, we first used the Surface Forces Apparatus to reveal that 3T3-L1 pre-
adipocytes exposed to tumor-secreted factors generate a stiffer Fn matrix relative to control cells. We
then show that this early matrix stiffening correlates with increased molecular unfolding in Fn fibers, as
determined by F€orster Resonance Energy Transfer. Finally, we assessed the resulting changes in adhesion
and proangiogenic factor (VEGF) secretion of newly seeded 3T3-L1s, and we examined altered integrin
specificity as a potential mechanism of modified cellematrix interactions through integrin blockers. Our
data indicate that tumor-conditioned Fn decreases adhesion while enhancing VEGF secretion by pre-
adipocytes, and that an integrin switch is responsible for such changes. Collectively, our findings suggest
that simultaneous stiffening and unfolding of initially deposited tumor-conditioned Fn alters both
adhesion and proangiogenic behavior of surrounding stromal cells, likely promoting vascularization and
growth of the breast tumor. This work enhances our knowledge of cell e Fn matrix interactions that may
be exploited for other biomaterials-based applications, including advanced tissue engineering
approaches.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Varied physicochemical properties of the extracellular matrix
(ECM), a dynamic and complex fibrillar network, modulate cellular
behavior. In tumors, the ECM is primarily generated by cancer-
associated cells (e.g. fibroblasts and adipogenic precursors) and
contributes to sustained tumor growth and survival [1e8]. It ex-
hibits numerous altered materials properties relative to normal
ECM including variations in protein composition, structure, andcience and Engineering, Cor-
el.: þ1 607 255 1623; fax: þ1
Ltd. This is an open access article urigidity. In fact, analysis of tumorous ECMs revealed differences in
collagen I deposition relative to normal ECMs as suggested by
elevated quantities, reorganization, crosslinking, and stiffness of
collagen [4,9e13]. Moreover, fibronectin (Fn) might be responsible
for additional ECM structural alterations, as indicated by the pres-
ence of highly stretched and unfolded Fn fibers in tumor-associated
matrices [14,15]. It is important to recognize that tumor-associated
Fn and collagen alterations are functionally linked since Fn (i) is
essential for the deposition of collagen I in ECMs [4,16e18] and (ii)
is also used as an indicator for increased tumor aggressiveness [19].
Nevertheless, a clear correlation between structural, conforma-
tional, and mechanical properties of the tumorous ECM network
and the role of Fn in this process has not been established. This
correlation has been hindered partly by the intrinsic complex
composition of the ECM, and by the lack of analytical tools thatnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the matrix/cellular to the molecular scale. Indeed, both collagen
and Fn fibers are present in mature ECM and likely synergize to
modulate the bulk properties of the tumor ECM [17,20]. Addition-
ally, there is a lack of materials science tools to separately assess
morphology and mechanics of native (uncrosslinked) ECM at both
matrix/cellular and molecular scales under physiologically relevant
conditions.
Altered materials properties of the tumor ECM are clinically
relevant as they promote tumor malignancy via direct effects on
tumor cells [8] and indirectly by enhancing the formation of new
blood vessels (angiogenesis) [4,9e13]. In fact, altered ECM can
enhance angiogenesis either by increasing the activity of sur-
rounding endothelial cells [14,15] or by stimulating the secretion of
proangiogenic factors (e.g. vascular endothelial growth factor
[VEGF]) from cancer-associated fibroblasts [4,16e18]. However, the
specific ECM properties and associated mechanisms responsible for
the proangiogenic capability of tumor-associated cells remain
unclear.
Here, we integrated a set of physical sciences tools with cancer
biology to: (i) characterize the mechanics, conformation, and to-
pology of tumor-associated Fn matrices at both the matrix and
molecular scales, and (ii) correlate these materials properties with
adhesion and proangiogenic factor (VEGF) secretion of adipose
stromal cells. Our results revealed that tumor-conditioned Fn
matrices were stiffer and more unfolded than control matrices, and
that these dysregulated matrices contributed to enhanced VEGF
secretion by stromal cells.
2. Materials and methods
2.1. Cell culture
As an in vitro model of cancer-associated stromal cells, we utilized tumor-
associated 3T3-L1 preadipocytes (ATCC, VA). Tumor soluble factors (TSF) from an
aggressive metastatic breast cancer line, MDA-MB231 cells (ATCC, VA), were
collected to mimic paracrine signaling between a tumor and its surrounding
microenvironment. After exposing 3T3-L1s to TSF for 3 days, the preconditioned
cells were detached and cultured on mica substrates for 24 h. Afterwards, culture
systems were decellularized [19,21] and the resulting cell-free matrices were used
for parallel mechanical, topological, and conformational characterization.
2.2. Surface forces apparatus
The Surface Forces Apparatus (SFA) (SurForce LLC, CA) is an interferometry-
based technique that uses fringes of equal chromatic order (FECO) to quantify the
absolute surface separation between two reflecting surfaces, with nm resolution,
while both normal (adhesion) and lateral (friction) forces can be measured. This
technique is extensively described in Refs. [17,20,22,23]. Briefly, in our study, the
lower surface was mounted on a double cantilever spring of known elastic constant
while the upper surface was connected to a step motor to apply normal load on the
lower surface. A white light source was directed through two SFA surfaces (silica
discs) previously glued with semi-reflective silvered mica, building an optical
interferometer. The resulting interference FECO were directed towards the entrance
slit of a photo-spectrometer (Princeton Instruments, NJ) and recorded with a CCD
camera (Princeton Instruments, NJ) for further FECO analysis. The acquisition soft-
ware used was LightField v4.0 (Princeton Instruments, NJ).
2.3. Substrate preparation for SFA characterization
Muscovite mica (S&J Trading, Australia) is a negatively charged, hydrophilic
aluminosilicate that is used as preliminary substrate in all SFA experiments. To
obtain transparent, uniform, and atomically smooth mica surfaces, we cleaved mica
into 1 cm2 sections of 2e5 mm in thickness and metallized themwith 55 nm of silver
to make them semi-reflective. The mica sections (silver side facing down) were then
glued with UV curing glue (E ¼ 1.034 GPa, product 61) (Norland, NJ) onto semi-
cylindrical silica discs of 10 mm in diameter and 20 mm of curvature radius (ESCO
Products, NJ). All preparation steps were performed in a laminar flow cabinet to
minimize particulate contamination. Each SFA experiment requires a pair of discs
glued with mica sections cut from the same sheet to ensure equal mica thicknesses
on both upper and lower discs. Customized PDMS chambers containing cell culture
media were used to house the lower discs during the 24 h matrix deposition process
while the upper discs (bare mica), used as indenters during force measurements,
were kept clean and stored in a desiccator until needed.2.4. Force curve acquisition and elastic measurements via SFA
Upper and lower SFA cylindrical discs were mounted in a crossed axis config-
uration to ensure awell-defined circular contact junction. The lower disc holding the
ECM was mounted on a 980 N/m spring and the upper disc (bare mica) was used to
indent ECM, as depicted in Fig. 1A. The SFA stainless steel chamber was filled with
75 mL of warm (37 C) PBS to keep the ECM in physiological conditions during
mechanical characterization, and the entire system was allowed to equilibrate at
37 C for 1 h. Each ECM was then probed at 4 different locations (approximately
500 mm apart) and each location was indented 3 consecutive times. The systemwas
allowed to equilibrate for 30 min between each indentation and 15 min between
locations. Approach (In) and retraction (Out) measurements (force runs) were per-
formed in quasi-static conditions (at a constant speed of 0.5 mm/min) to minimize
viscous effects. During force runs, FECO were acquired at a rate of 3 frames per
second and post-processed with Matlab R2012b (MathWorks, MA) to yield
forceedistance profiles. These profiles were further analyzed to extract the
compressive elastic moduli using Hertzian contact mechanics between a sphere and
an elastic half-space proposed by Johnson [8,24], equation (1) (see Results).2.5. Creep testing via SFA
Samples were prepared and mounted in the SFA as described in the previous
section. However, the lower surface was mounted onto a more compliant spring
(k ¼ 676 N/m) and the ECM samples were indented instantaneously (rather than
quasi-statically) by applying increasing step-loads of approximately 3.7 mN
(indentation approximately 5 mm) using the SFA fine micrometer, resulting in forces
that correspond to F1 ¼ F01 ¼ 3.7 mN, F2 ¼ F02 ¼ 7.4 mN, and F03 ¼ 11.1 mN. Changes in
ECM indentation depth (creep) were then monitored over 1800 s by following the
shift of the FECO fringes.2.6. FRET labeling of fibronectin
Alexa Fluor 488 succinimydyl ester (donor fluorophores) and Alexa Fluor 546
maleimide (acceptor fluorophores) (Invitrogen, CA) were used to label Fn for
intramolecular F€orster Resonance Energy Transfer (FRET) as previously described by
Baneyx et al. [25] and Smith et al. [26]. Fn concentrations and labeling ratios be-
tween donors and acceptors were determined using a DU®730 UVeVis spectro-
photometer (Beckman, IN) at 280 nm, 495 nm, and 556 nm. FRET calibration of
labeled Fn was first carried out in denaturant solution by varying guanidine hy-
drochloride concentrations between 0 and 4 M to obtain acceptor/donor intensity
ratios (IA/ID), termed FRET ratios, as a function of protein denaturation. Additional
FRET calibration of Fn embedded in fibers was performed via a custom-made strain
device and used to correlate Fn fiber FRET ratios with fiber uniaxial strain, as
described in Refs. [27,28].2.7. Cell seeding and sample decellularization
3T3-L1 (ATCC, VA) preadipocytes (passages 4e10) were preconditioned for 3
days in either a-MEM culture medium (Control) or a-MEM medium containing
normalized TSF. After this preconditioning period, cells were trypsinized and used
for parallel SFA and FRET experiments.
Both flat mica sections (culture area: 64e81 mm2/well) and curved mica sur-
faces (mounted on SFA discs, culture area: 80 mm2/disc) in PDMS chambers were
first incubated with human plasma Fn (Life Technologies, NY) at a concentration of
30 mg/mL in phosphate buffered saline (PBS) for 60 min at room temperature to
facilitate cell adhesion. After rinsing 3 times with PBS, a concentrated cell solution
comprised 2  104 preconditioned 3T3-L1s (Control or Tumor) was seeded on the
mica substrates. After 20 min of cell adhesion, 400 mL of exogenous Fn (50 mg/mL)
low serum (1% fetal bovine serum (FBS)) was added. For FRET experiments, the
exogenous Fn consisted of 90% unlabeled Fn (unFN) and 10% FRET-labeled Fn to
prevent intermolecular FRET. For SFA experiments, only unFN was used.
After culturing at 37 C and 5% CO2 for 24 h, cultures were decellularized via a
modified Cukierman protocol [21] that included deoxycholic acid incubation and
extra wash steps, and left unfixed in PBS. Further samples were fixed for 1 h at 4 C,
and washed three times with PBS for immunostaining and morphology studies.2.8. FRET data acquisition
Samples were imaged with a Zeiss 710 confocal microscope (Zeiss, Munich,
Germany) using the C-apochromat water-immersion 40/1.2 objective, a pinhole of
2 AU, a 488 nm laser set at 10% power, and a pixel dwell time of 6.3 ms to acquire 16-
bit z-stack images spaced 2 mm apart. FRET-Fn fluorescence was simultaneously
collected for the donor fluorophores in the PMT1 channel (514e526 nm) and for the
acceptor fluorophores in the PMT2 channel (566e578 nm), in addition of brightfield
imaging. Donor and acceptor z-stack images were analyzed pixel by pixel with a
customized Matlab code to generate false color FRET ratio (IA/ID) images and FRET
histograms for each image. Individual FRET z-stack images were stacked in ImageJ
(NIH) and reconstructed in Volocity (PerkinElmer, Inc., MA) [26,29,30].
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ECMswere decellularized and fixed as previously described [21]. The ECMswere
washed with 0.05% Triton X-100 (Thermo Scientific, IL) in PBS (PBS-X) for 5 min,
then blocked for non-specific binding with PBS-X containing 1% SuperBlock
(Thermo Scientific, IL). After washing twice with PBS-X, the samples were immu-
nostained overnight at 4 C for: Fn using either rabbit or mouse (when co-staining
collagen I) antibodies (SigmaeAldrich, MO), rabbit anti-mouse collagen I (Millipore,
MA), mouse anti-talin (Millipore, MA), or rabbit phosphorylated focal adhesion ki-
nase [pY379] (pFAK) (Invitrogen, CA). After overnight incubation, the samples were
washed twice with PBS-X for 5 min each, and incubated for 1 h at room temperature
in a PBS-X/1% SuperBlock solution of the following formulations: DAPI (Life Tech-
nologies, NY) (1:5000), Alexa Fluor 568 Phalloidin (1:250), goat anti-rabbit Alexa
Fluor 488 (1:100) or goat anti-mouse Alexa Fluor 488 (1:100), goat anti-mouse Alexa
Fluor 647 (1:100) (All Alexa Fluorophores were obtained from Life Technologies,
NY). After the secondary antibody incubation, samples werewashed twicewith PBS-
X for 5 min, and kept in PBS for confocal microscopy imaging.
2.10. Analysis of matrix porosity and fiber diameter
Fn fiber diameters and matrix pore sizes were obtained from immunostained
confocal microscope images and analyzed using ImageJ (NIH). To this end, 7 z-stack
slices were orthogonally projected. Measurements were taken from random loca-
tions (including both central and peripheral sample areas). Pore size was analyzed
by measuring the average size of the empty spaces with fibers within the projection
(as depicted in Fig. 3B).
2.11. VEGF secretion on cell-derived matrices
Preconditioned preadipocytes were seeded on Fn coated flat mica surfaces for
24 h as previously described. To compare between VEGF secretion and matrix
sequestration, media was collected and cultures were decellularized and scraped,
respectively. To understand how Fn matrix binding affects VEGF secretion, samples
were decellularized, blocked for non-specific binding with PBS containing 1% bovine
serum albumin for 20 min, sterilized with penicillin-streptomycin overnight, and
washed twicewith PBS. Untreated preadipocytes were trypsinized and suspended in
serum freemediawith various integrin-blocking antibodies (3 mg/mL) on a shaker at
37 C for 30 min. Cells were either left untreated, treated with only a rat anti-mouse
integrin av blocker (CD51) (Millipore, MA), treated with only a rat anti-mouse b1
blocker (CD29) (BD Biosciences, CA), or treated with both integrin blockers simul-
taneously. Cells were then allowed to attach in serum free media at 37 C for 1 h,
before switching to low serum media (1% FBS). After 3 h (total 4hr), the media were
collected to quantify VEGF secretion with a Quantikine ELISA kit (R & D Systems,
MN) and samples either extracted for DNA in Caron's buffer or fixed, immuno-
stained, and imaged as previously described. VEGF secretion was normalized by mg
of DNA for each corresponding sample and represented as a ratio relative to
normalized VEGF secretion by untreated cells on control ECMs.
2.12. Statistics
Data were statistically analyzed in GraphPad Prism (GraphPad Software, Inc.,
CA). Student's t-tests or ANOVAs with Tukey's post-hoc tests were performed and
statistical significance was determined at p < 0.05.
3. Results
3.1. Tumor-conditioned cells promote matrix stiffening through
early altered Fn assembly
To evaluate if tumor cell-secreted factors alter ECM deposition
by adipose stromal cells, a major cell type in the mammary
microenvironment, we first used the Surface Forces Apparatus
(SFA) to assess the overall rigidity of matrices deposited by tumor-
associated and control 3T3-L1 preadipocytes (See Fig. 1). The SFA
allows one to run compressive tests by determining the absolute
distance D between two semi-reflecting smooth mica surfaces
mounted on silica discs (Fig. 1A) using interferometric fringes
patterns (Fig. 1B) while applying normal forces F via a double
cantilever spring [22,23]. Briefly, tumor-associated and control
3T3-L1 cells were seeded onto the lower SFA mica disk in Fn-
containing medium for 24 h (Fig. 1C) and later removed with
decellularization buffer leaving behind a cell-free fibrillar ECM
comprising Fn fibers (Fig. 1D, Fig. S1A). Compressive measurements
were then performed in the quasi-static regime via the upper SFA
(bare) mica disk and forceedistance profiles were acquired
(Fig. 1E). Data were further analyzed to extract elastic moduli usingJohnson contact mechanics [24], in which the indentation of the
matrix under compression d is related to the normal force F by the
following equation:
F
R
¼ Ep d
2
D0
(1)
where R is the radius of curvature of the discs, D0 is the matrix
thickness at rest, and E the resulting Young modulus. Elastic moduli
were calculated over a 25% strain range (Fig. 1F) and force
normalized by radius of curvature (F/R) plotted as a function of
thickness parameter d2/D0 was used as control for the fit quality
(Fig. S1B). We found that the mean elastic moduli of unfixed/native
tumor-associated ECM were significantly higher than those of
control matrices (E ¼ 0.12 ± 0.04 vs. 0.07 ± 0.03 kPa, p < 0.001).
We have also tested the effect of in situ chemical fixation of the
matrices (with neutral buffered formalin) on their rigidity and
found it increased the stiffness of both tumor-associated and con-
trol matrices by 22% and 19%, respectively (E ¼ 0.14 ± 0.06 vs.
0.09 ± 0.05 kPa, p < 0.002) (Fig. S2), while the overall stiffening of
tumor-associated matrices was maintained. These data indicate
how essential it is to assess mechanical properties of cell-derived
materials in their native state instead of using fixatives, which
promotes extra stiffening (here by ~20%).
Since the ECM is a viscoelastic material, we next analyzed its
creep response by applying instantaneous force and recording
changes in ECM indentation depth (Dd) over time (Fig. S3A). Our
results indicate two time-dependent regimes that could be well
fitted by a double exponential decay:
DdðtÞ ¼ A1e
t
t1 þ A2e
t
t2 (2)
whereDd (t) is thematrix thickness decay, t1 and t2 are the fast and
slow characteristic decay times, respectively, and A1 and A2 are the
decay amplitudes used as fitting parameters. Tumor-conditioned
matrices indicated longer decay times than control matrices in
both the fast [t1 ¼ 125 ± 30 vs. 47 ± 25 s] and the slow
[t2 ¼ 1048 ± 152 vs. 701 ± 107 s] regimes, suggesting a trend of
overall slower responses of tumor-associated Fn matrices to
external forces (Fig. S3B).
Collectively, these data indicate that, besides being stiffer,
tumor-conditioned matrices may also be more viscous than their
control counterpart, which is likely able to dysregulate mechano-
signaling to surrounding cells. Although we could not find any
previous report of tumor ECM viscoelasticity, our matrix creep data
are in agreement with the enhanced viscosity detected in breast
cancer [31] and prostate cancer [32] tissues. The relative poroelastic
and viscoelastic contributions to the matrix characteristic decay
times reported here are discussed later.
3.2. Early tumor-conditioned matrices comprise highly stretched
and unfolded Fn fibers
Wenext combined FRETand confocal microscopy tomonitor the
incorporation of FRET-labeled Fn into newly developed fibrils over
24 h, as previously described in Ref. [26] and calibrated in detail in
Ref. [15] (Fig. 2). Our in situ FRET mapping shows that control cells
(Fig. 2A) deposited high and medium FRET-Fn fibers (yellow and
green pixels) indicative of the coexistence of close-to-compact and
extended Fn conformations. In contrast, tumor-associated cells
(Fig. 2B) generated mostly stretched and unfolded Fn fibers, as
indicated by low FRET fibrillar sections (blue pixels). Overall,
tumor-associated matrices displayed both a more homogenous Fn
population (narrower FRET histogram in Fig. 2C) and more
stretched Fn fibers than control matrices (mean FRET intensity
***
A
E F
C
B
D
Fig. 1. Tumor-associated Fn matrices are stiffer. (A) Schematics of the Surface Forces Apparatus (SFA) mica surfaces and setup used for mechanical characterization of the matrices at
37 C. (B) Interference fringes measured with the SFA when shining white light through the confining surfaces at large (uncompressed matrix) and small (compressed matrix)
separations. (C) Immunostaining of tumor-conditioned stromal cells embedded in their ECM after 24 h of culture onto SFA mica surfaces (green, Fn; red, F-actin; and blue, nuclei).
(D) Same as (C) after decellularization (cell extraction) showing the Fn matrix left behind. Scale bars ¼ 50 mm. (E) To determine Fn matrix stiffness, compressive forceedistance
profiles were acquired in quasi-static conditions in control (B) and tumor-associated (C) conditions and fitted using a Hertzian model. (F) Mean tumor-associated matrix elastic
moduli (n ¼ 18) were ~60% higher than those of control matrices (n ¼ 20). (For interpretation of the references to color in this figure legend, the reader is referred to the web version
of this article.)
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is in agreement with previously published results [15]. Collectively,
our data suggest that tumor-conditioned cells deposit Fn fibers
with altered conformations that might alter Fn signaling either by
exposing new binding sites to cells or by disrupting strain-sensitive
binding motives such as the PHSRN synergy site and the RGD loop
sequence responsible for a5b1 integrin binding [33,34].
When testing the effect of Fn matrix chemical fixation on FRET,
we found it increased the FRET ratio of control matrices (Fig. S4A)
but had no effect on the FRET of tumor-conditioned (Fig. S4B)
matrices, relative to unfixed conditions, denoting an overall strain
relaxation and enhancing the differences between tumor-
associated and control matrices (mean FRET intensity
ratio ¼ 0.35 ± 0.06 vs. 0.45 ± 0.05) (Fig. S4C, D).
3.3. Early tumor-conditioned Fn matrices are thicker, denser, and
comprise thicker fibers
We next investigated the topology of the Fn matrices. We first
used the SFA to assess ECM thickness (Fig. 3A) and show thattumor-conditioned cells generated a 37% thicker matrix than con-
trol cells (D0 ¼ 18.9 ± 1.7 vs. 13.7 ± 0.8 mm, p < 0.03). Next, z-pro-
jections of 3D reconstructed confocal image stacks (Fig. 3B) were
used to quantify pore sizes and fiber diameters using ImageJ (NIH).
We found that tumor-associated matrices were also denser, as
indicated by smaller pores than in control matrices (73.3 ± 96.5 vs.
131.8 ± 179.8 mm2) (Fig. 3C) and displayed Fn fibers with larger
diameters (ØTumor ¼ 1.10 ± 0.42 mm) than control matrices
(ØControl¼ 0.89 ± 0.31 mm) (Fig. 3D). Collectively, our data show that
the topology of tumor-associated matrices is also altered: indeed,
narrower pores and thicker Fn fibers likely contribute to enhanced
matrix rigidity as well as altered cell binding and migration.
3.4. Early tumor-conditioned Fn matrices rapidly increase stromal
cell proangiogenic factor secretion
To determine the relevance of our results in tumor angiogenesis,
we next assessed the proangiogenic capability of fresh 3T3-L1s
after their seeding onto the Fn matrices via quantification of
vascular endothelial growth factor (VEGF) secretion after 4 h. This
***
A
C D
B
Fig. 2. Tumor-associated Fn matrices are more unfolded. (A, B) FRET-Fn maps showed lower FRET intensity ratios, IA/ID, in tumor matrices (blue Fn fibers) than in their control
counterpart (green/yellow Fn fibers). Scale bars ¼ 50 mm. (C) Corresponding FRET intensity ratio histograms confirmed that tumor-associated Fn matrices comprised mainly
stretched/unfolded Fn fibers (low FRET, narrow distribution) while control matrices contained a broader population of Fn conformations (higher FRET, larger distribution). (D) Mean
FRET intensity ratios, IA/ID, of tumor-associated Fn matrices (n ¼ 171) were lower than that of control matrices (n ¼ 245), indicating that tumor conditions increased unfolding by
~10% with respect to control. Mean ± SD. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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primarily consisting of Fn that has not yet been remodeled. Inter-
estingly, our data indicate that tumor-conditioned Fn matrices
inhibited adhesion (40%) relative to control (data not shown), while
VEGF secretion was significantly enhanced in the tumor-
conditioned ECMs compared to their control counterparts (34%,
1.338 ± 0.472 relative to control vs. 1 ± 0.318) (Fig. 4A). We
attributed different levels of VEGF to altered secretion
(1.326 ± 0.026 relative to control vs. 1 ± 0.105) rather than altered
matrix sequestration after we analyzed Fn-matrix lysates indi-
cating negligible amounts of Fn matrix-bound VEGF (approxi-
mately 9% of VEGF measured in the media) with no significant
differences between tumor and control matrix conditions*
A B
Fig. 3. Tumor-associated Fn matrices are thicker, denser, and comprised thicker fibers. (A) T
matrices (n ¼ 17). (B) Z-projections of immunostained control and tumor-associated Fn matr
diameter shown in panels (C) and (D), respectively. (C) Pores measured within tumor-associa
matrices (n ¼ 72) (p < 0.0001). (D) Tumor-associated Fn fibers (n ¼ 120) possessed larger(0.086 ± 0.002 relative to control vs. 0.091 ± 0.018) (Fig. 4B).
Because Fn conformational changes were previously shown to
modulate the binding specificity of integrins [35e39], we also
examined altered integrin specificity as a potential mechanism of
tumor-induced modified signaling. We initially tested whether
introducing integrin blockers would alter VEGF secretion by
exposing unconditioned 3T3-L1s to av blockers on control matrices
and b1 blockers on tumor matrices. We detected no significant
difference in VEGF secretion on control and tumor matrices,
respectively (Fig. 4C, þ/ white bar and /þ gray bar). We first
tested the role of a5b1 integrins in regulating VEGF secretion by
exposing fresh cells to b1 blockers prior to seeding. Our data indi-
cate that blockade of b1 dramatically increased VEGF secretion* ***
DC
umor-associated Fn matrices (n ¼ 21) measured by the SFA were thicker than control
ices. Scale bars ¼ 50 mm. Insets: 300% zooms used to determine the pore size and fiber
ted Fn matrices (n ¼ 72) were significantly smaller than those measured within control
diameters than those of control Fn fibers (n ¼ 120) (p < 0.05). Mean ± SD.
AC
B
*
*
***
Fig. 4. Cells adhere to tumor-associated Fn preferentially through av integrins with
associated increased VEGF secretion. (A) After 4 h, new (untreated) cells secreted
significantly higher levels of VEGF when seeded onto tumor-associated Fn
(1.338 ± 0.472 relative to control, n ¼ 13) than those seeded onto control Fn (1 ± 0.318,
n ¼ 14) (p < 0.05). (B) There were differences in VEGF secretion (1.326 ± 0.026 relative
to control vs. 1 ± 0.105) but not in matrix sequestration from the same samples after
24 h cultures (0.086 ± 0.002 relative to control vs. 0.091 ± 0.018). n ¼ 2/group. (C) After
4 h, cells treated with b1-integrin blockers and seeded onto control ECMs secreted
significantly higher levels of VEGF than untreated cells (2.153 ± 0.246 relative to
control, n ¼ 6 vs. 1 ± 0.318, n ¼ 14) (p < 0.0001). When cells treated with av-integrin
blockers were seeded onto control ECMs, no change in VEGF secretion was detected
compared to untreated cells (1 ± 0.449, n ¼ 4). Cells treated with av-integrin blockers
and seeded onto tumor ECMs secreted slightly lower levels of VEGF than untreated
cells (1.242 ± 0.392 relative to control, n ¼ 6 vs. 1.338 ± 0.472, n ¼ 13). For cells treated
with b1-integrin blockers on tumor ECMs, there was an insignificant decrease in VEGF
secretion compared to untreated cells (1.098 ± 0.108, n ¼ 4). As a control, cells treated
with both integrin blockers secreted lower levels of VEGF on both control
(0.767 ± 0.253, n ¼ 6) and tumor ECMs (0.828 ± 0.126, n ¼ 6). Mean ± SD.
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white bars) indicating that a5b1-mediated interactions with control
Fn, may contribute to low VEGF secretion levels by stromal cells.
This effect was inhibited by simultaneous addition of an av
function-blocking antibody (Fig. 4C, þ/þ white bars), suggesting
that avb3 may play a role in this process. We next tested the
contribution of avb3 to increased VEGF secretion of cells interacting
with tumor Fn. However, exposure of cells to av blockers prior to
seeding led to a slight decrease in VEGF secretion (Fig. 4C, /
and þ/ gray bars), while concomitant blockade of both av and b1
subunits further lowered VEGF secretion (Fig. 4C, þ/þ gray bars),
suggesting Fn-mediated complex integrin compensatory mecha-
nisms [40]. Collectively, our data indicate that the presence of
unfolded and stiff Fn fibers in tumor-conditioned matrices en-
hances 3T3-L1 secretion of VEGF by altering their use of avb3 over
a5b1 integrins. These results are discussed later and are inagreement with previous work by others showing a direct link
between avb3 engagement and increased VEGF secretion [41].
Because cells respond to altered matrices by modulating their
adhesive linkages, we further investigated cell adhesions by
monitoring the recruitment of two focal adhesion proteins. Our
data reveal differences in both talin and phosphorylated focal
adhesion kinase (pFAK [pY397]) distribution among cells reseeded
on control or tumor-associated matrices (Fig. S5). On control Fn,
untreated cells recruited both talin and pFAK to develop fibrillar
adhesions (insets: double arrows); instead, cells treated with b1
blockers grew adhesive ECM clusters comprising mainly talin
(Fig. S5, control). On tumor-conditioned Fn, untreated cells devel-
oped focal contacts comprising both talin and pFAK (insets: ar-
rowheads) while cells treated with av blockers began developing
fibrillar adhesion located mainly at the cell periphery (insets:
double arrows) (Fig. S5, tumor). Interestingly, cells treated with
both integrin blockers developed peripheral fibrillar adhesions on
control Fn, and left behind ECM clusters on tumor-associated Fn.
Our findings are in agreement with previous work showing that
focal contacts comprise primarily avb3 integrins whereas fibrillar
(or mature) adhesions contain principally a5b1 integrins [42]. These
different adhesions are activated through different mechanisms:
while a5b1 integrins cluster and recruit adhesion proteins in a
contractility-independent manner [43], avb3 integrins require cell
contractility to develop nascent adhesions via talin [44], which
regulates avb3 activation via a conformational change of b3 rein-
forcing nascent focal contacts [45e47]. Our findings indicate that
cells forced to utilize avb3 integrins on stiff and unfolded tumor-
associated matrices recruit higher levels of talin to form large
focal contacts, which may also modulate proangiogenic behavior.
4. Discussion
The experiments presented herein suggest that breast cancer
cell-secreted factors deregulate early Fn matrix assembly by stro-
mal cells. Increased levels of Fn had been previously detected in
tumors [48], and plasma Fn is implicated in tumor growth [49]. Our
findings additionally indicate that the mechanical and the struc-
tural/conformational properties of Fnmay be different in tumors vs.
controls as matrices deposited by stromal cells in response to
tumor-secreted factors exhibited increased overall stiffness, fiber
stretching, and molecular unfolding. Moreover, these Fn alterations
were linked to enhanced proangiogenic capability of the stromal
cells with potential implications for tumor angiogenesis.
More specifically, tumor-conditioned matrices are mechanically
different from control matrices as they exhibit increased stiffness.
Our work also suggests that tumor-conditioned matrices have
slower changes in indentation depth, indicative of both elastic and
time-dependent (viscous) modifications. Furthermore, these
matrices are structurally (and conformationally) altered across
multiple length scales as they are overall thicker, denser, and
composed of thicker fibers that comprise more unfolded Fn mole-
cules. By combining the SFAwith FRETmapping, our study provides
a detailed picture of the early deposited Fn matrix from the matrix/
cellular level to the molecular level. Our results are in accordance
with work of previous investigators but also include new obser-
vations with direct implications on Fn-mediated tumor-stroma
progression.
At the single fiber level, previous FRET work had shown that
strain application to manually-extruded Fn fibers led to stiffening
and unfolding (above 150% strain) in these fibers [26]. At the matrix
level, another FRET study [15] estimated the average strain in cell-
derived Fn fibers based on a FRET vs. strain calibration (performed
on single manually-extruded fibers) and anticipated matrix stiff-
ening although no direct measurement of matrix stiffness was
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tative and direct correlation between overall Fn matrix stiffness
and topology at the matrix/cellular scale with Fn conformations at
the molecular scale.
Our findings also underline how dramatic the effect of fixatives
(commonly used in laboratories) can be on both the mechanical
and structural properties of compliant (0.1 kPa range) and porous
materials. Indeed, although the general trends of stiffening and
unfolding were maintained for tumor-conditioned relative to con-
trol matrices, formalin increased rigidity and decreased strain (as
indicated by a FRET increase), particularly in control Fn matrices
where the random crosslinking of lysines likely resulted in the
pinning of dangling/relaxed Fn fibers in the network.
Our stiffness data indicate lower values for tumor-conditioned
Fn matrices than for both macroscopic tumors in vivo [50] and
single Fn fibers [27]. These difference can be attributed to (i) the
higher porosity of cell-free Fn networks (with enhanced fluid
transport) relative to the denser tumor tissue, (ii) the presence of
both Fn and collagen in mature tumor tissues, and (iii) the different
regime of deformations in individual fibers relative to ECM net-
works, where the deformation (here compression) is distributed
over a mesh of disordered and connected fibers that respond
collectively to stress by initially aligning/ordering along the
compressive surface before being further indented. Moreover our
creep data indicate a trend of slower responses of tumor-
conditioned matrices with respect to their control counterparts,
with characteristic decay times of the order of 102 and 103 s for (t1)
and (t2), comparable to the time of observation in our experiments.
A simple calculation of the characteristic time for solvent molecules
to be diffused through the Fn matrix, i.e., so-called poroelastic time
tp, assuming a typical radius of contact between SFA surfaces of
10 mmand a diffusion constant for cells and tissues of 10e100 mm2/s
[51,52] leads to tp ¼ 1e10 s, i.e., 10 to 100 times faster than the
measured (t1) and (t2), Hence our results suggest that although
poroelastic processes contribute to the biphasic system (Fn
network þ solvent) relaxation at shorter timescales, the longer
decay times we report here are mainly due to viscoelasticity, i.e.,
conformational/structural changes in the Fn network rather than to
solvent redistribution through the matrix pores.
Additionally, to obtain cell-derived Fn matrices, we used a well
established protocol [21] comprising a mild detergent and multiple
washing steps. Decellularizing matrices has previously been shown
to (i) relax matrix networks by ~20% [53], and (ii) alter the ratio of
DOC soluble (nascent) to DOC insoluble (crosslinked) Fn charac-
terized herein [54], as DOC soluble Fn will have most likely been
washed away. Although these effects should not alter our results,
which report relative differences between control and tumor-
conditioned decellularized matrices, future studies will be
required to delineate the potential contribution of both relaxation
and loss of fibrillar heterogeneity on these matrices, in particular by
developing new (less invasive) decellularization protocols.
Matrix topology (denser network and thicker fibers) together
withmolecular unfolding of the initial Fnmatrix may also influence
indirectly the overall tumor-conditioned matrix mechanics. Addi-
tionally, on one hand, Fn unfolding has been shown to lead to the
subsequent deposition of a more unfolded Fn matrix [29]. On the
other hand, altered Fn characteristics might modulate tumor stiff-
ness by altering the deposition of subsequent ECM components. For
example, Fn fibers act as templates for the deposition of collagen
[55]. In particular, the specific binding of collagen I a1 chain to the
gelatin-binding domain of Fn (located on FnI6, FnII1-2, and Fn III7-9)
is necessary for the initial co-deposition of collagen [56]. Because
the interaction of Fn with collagen is likely conformation depen-
dent, the unfolded/highly strained Fn fibers initially generated by
3T3-L1s may dramatically affect collagen fibrillogenesis, either bydisrupting the exposed binding site for collagen I or by exposing
cryptic sites with enzymatic activity such as Fn type IV Col-ase,
which is a matrix metalloprotease in the collagen binding domain
of Fn capable of digesting collagen [57]. Consequently, Fn unfolding
may also indirectly regulate the mechanosignaling of tumor-
associated collagen I that ultimately contributes to tumorigenesis
[11e13].
In this study, we also report that new (untreated) stromal cells
seeded onto tumor-associated matrices exhibit decreased adhesion
and enhanced VEGF secretion. Because tumor-conditioned Fn
matrices exhibit topological, conformational, and mechanical al-
terations known to alter cellematrix interactions, we hypothesized
that Fn alterations might serve as a mechanosensor and “integrin
switch”. Tumor-conditioned Fn ECMs were characterized to be
dense matrices comprising thick fibers. Thicker fibers may alter
ligand density, which in turn, would alter stable focal adhesion
formation and downstream cellular behavior [58e61]. As increased
ligand density might be another mechanism behind altered cell-Fn
matrix interactions in tumors, future studies are needed to probe
how antagonizing RGD binding sites could alleviate (in a dose-
dependent manner) subsequent cell behavior in tumors. Our re-
sults indicate that the cells responsible for enhanced VEGF secre-
tion detected on tumor-associated matrices (comprising mainly
stretched/unfolded Fn fibers) tend to favor the use of avb3 over a5b1
integrins to interact with Fn. This finding can be explained by dif-
ferential engagement of either strain-sensitive (e.g., a5b1) or strain-
insensitive (e.g., avb3) integrins with the surrounding matrix.
Indeed, the integrin binding FnIII9-III10 sequence of Fn is extremely
sensitive to conformational changes resulting from enhanced ten-
sion exerted by cells. Earlier reports suggested that the distance
between the “synergy” PHSRN site in FnIII9 and the RGD site in
FnIII10 is critical for engagement and activation of integrin a5b1
[62,63] but has little effect on engagement of integrin avb3.
Therefore the “integrin switch” measured here on tumor-
conditioned matrices may be in part explained by strain-induced
increased spatial separation between FnIII9 and FnIII10 [35],
which inhibits the binding of a5b1 to both sites simultaneously [34]
and forces cells to utilize more avb3 to compensate [36]. Our results
are in agreement with previous work showing that higher
engagement of avb3 increases VEGF secretion [38,41]. Moreover, we
see that b1 blockade of cells seeded on control (relaxed) Fn had a
greater effect on VEGF secretion than av blockade of cells on tumor-
conditioned (stretched) Fn. This functional difference may be
attributed to VEGF receptor availability, as VEGF is immobilized to
Fn through a a5b1/VEGF-receptor [64]. This immobilization inhibits
the accessibility of a5b1, leading to VEGF release. Another expla-
nation of the functional difference could be that a5b1 has higher
binding affinity (4 nM) to Fn [65] than avb3 (1.3 mM) [66]. Never-
theless, the measured increase in VEGF secretion may be further
modulated by the physicochemical complexity of the tumor-
conditioned ECM. This complexity not only entails differences in
Fn stiffness and conformation (including different spatial distri-
bution of ligands at the fiber surface), but also varied quantity and
composition (e.g. proteoglycans), which can all regulate the
observed integrin(s) switching effect. Though the difference in
VEGF secretion is small, it is significant, and comparable to our
previous studies in which similarly small differences in VEGF
secretion on dense andmature ECM networks significantly affected
endothelial cell behavior [38].
Collectively, our results contribute to an improved under-
standing of the role of early Fn matrix assembly in modulating
proangiogenic factor secretion of breast tumor-conditioned stromal
cells. Future experiments are needed to further clarify the role of Fn
in a 3D tissue-like context. Our studies have been performed on
cell-derived Fn-matrix coated mica surfaces, where both substrate
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behavior. In particular, the mica substrates used in our studies are
stiffer than the tumor tissue, which may affect the mechanics and
conformation of the deposited Fn matrix. Similarly, the formation
of focal adhesions differs in 2D and 3D cell cultures [67] which also
potentially modulates the properties of the Fn matrix. Future
studies will (i) validate our integrin-modulated VEGF secretion
findings in a physiologically relevant 3D matrix with controlled
stiffness and topology, (ii) allow us to discriminate the roles of
stiffness and conformation in regulating these processes [68], and
(iii) lead to new insights that may improve current anti-VEGF
therapies [69].
5. Conclusions
Our results indicate that, following exposure to breast cancer
cell-secreted factors, adipose stromal cells initially deposit in the
stroma, high amounts of stiff and unfolded Fnwith altered topology,
which deregulate the behavior of neighboring cells by modifying
cellematrix interactions (altered outside-in signaling). Our work
also indicates that such tumor-induced Fn matrix deregulation ac-
tivates integrin switches in surrounding cells ultimately enhancing
VEGF secretion with potential functional consequences on tumor
angiogenesis. These findings have important implications for our
understandingof tumor growth, as theysupport thenotionof Fn as a
key initiator of mammary tumor angiogenesis. This work also en-
hances our knowledge of cell e Fn matrix mechanobiological in-
teractions that may be exploited for other biomaterials-based
applications, including advanced tissue engineering approaches.
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